NAD+ supplements have become synonymous with longevity, but does increasing a biomarker automatically mean improving health?

In this episode of the Orange Pill Podcast, we unpack the regulatory showdown over Tru Niagen®, the growing scrutiny around “clinically proven” claims, and why raising NAD+ levels may not always translate into real-world benefits.

As longevity science advances, the question is shifting from Can we change biology? to Will consumers actually feel the difference?